Created at	Source	Raw Value	Validated value
June 25, 2024, noon	usa	inclusion criteria: * clinical diagnosis of covid-19 * clinical evidence of fatigue despite the passage of 30 to 60 days from the onset --of the symptoms of covid-19 * willingness and informed consent to participate in the study	inclusion criteria: * clinical diagnosis of covid-19 * clinical evidence of fatigue despite the passage of 30 to 60 days from the onset --of the symptoms of covid-19 * willingness and informed consent to participate in the study
Jan. 2, 2023, noon	usa	inclusion criteria: clinical diagnosis of covid-19 clinical evidence of fatigue despite the passage of 30 to 60 days from the onset --of the symptoms of covid-19 willingness and informed consent to participate in the study	inclusion criteria: clinical diagnosis of covid-19 clinical evidence of fatigue despite the passage of 30 to 60 days from the onset --of the symptoms of covid-19 willingness and informed consent to participate in the study